| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Jonathan Rosand | Q23765874 |
| Nurimu Mahmut Edip Gurol | Q37373980 | ||
| Audrey Leasure | Q57572933 | ||
| Kevin N Sheth | Q86075253 | ||
| Alessandro Biffi | Q91821855 | ||
| P2093 | author name string | Stefan Schwab | |
| Steven M Greenberg | |||
| Hooman Kamel | |||
| Daniel Woo | |||
| Jordan Elm | |||
| Alison M Ayres | |||
| Anand Viswanathan | |||
| Christopher D Anderson | |||
| Kristin Schwab | |||
| Fernando D Testai | |||
| Hagen B Huttner | |||
| Joji B Kuramatsu | |||
| Christina Kourkoulis | |||
| P2860 | cites work | Meta-analysis in clinical trials | Q27860779 |
| Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis | Q28196445 | ||
| Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association | Q28262545 | ||
| Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges | Q28287345 | ||
| The Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study protocol | Q30410544 | ||
| Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. | Q33874860 | ||
| A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey | Q34105149 | ||
| Assessment scales in stroke: clinimetric and clinical considerations. | Q34329733 | ||
| Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation | Q34677974 | ||
| Performance of time-dependent propensity scores: a pharmacoepidemiology case study | Q35091792 | ||
| The risk of recurrent stroke after intracerebral haemorrhage | Q36227183 | ||
| Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation | Q36501853 | ||
| Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage | Q36533789 | ||
| Interpretation of tests of heterogeneity and bias in meta-analysis | Q37329334 | ||
| Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis | Q38164972 | ||
| Risk adjustment of ischemic stroke outcomes for comparing hospital performance: a statement for healthcare professionals from the American Heart Association/American Stroke Association | Q38181313 | ||
| Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. | Q38415781 | ||
| Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study | Q38997508 | ||
| Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage | Q40857879 | ||
| Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial | Q43203769 | ||
| Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage | Q43424706 | ||
| Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE study | Q43458464 | ||
| Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes. | Q44813007 | ||
| Comparison of methods for estimating the number of true null hypotheses in multiplicity testing. | Q47416509 | ||
| One-to-many propensity score matching in cohort studies. | Q47789199 | ||
| The ABCs of measuring intracerebral hemorrhage volumes. | Q54430652 | ||
| European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage | Q57384692 | ||
| Rate of Stroke Recurrence in Patients With Primary Intracerebral Hemorrhage | Q57757183 | ||
| P433 | issue | 5 | |
| P921 | main subject | anticoagulation | Q63279445 |
| P304 | page(s) | 755-765 | |
| P577 | publication date | 2017-10-13 | |
| P1433 | published in | Annals of Neurology | Q564414 |
| P1476 | title | Oral Anticoagulation and Functional Outcome after Intracerebral Hemorrhage | |
| P478 | volume | 82 |
| Q92508817 | Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage |
| Q55047549 | Anticoagulation Resumption After Intracerebral Hemorrhage. |
| Q92955488 | Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline |
| Q57789140 | Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage |
| Q58703004 | Functional outcome and survival following spontaneous intracerebral hemorrhage: A retrospective population-based study |
| Q52807848 | Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves |
| Q90364234 | Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events |
| Q57494697 | Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes |
| Q92499663 | Prognosis of poststroke epilepsy |
| Q55354315 | Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: systematic review and meta-analysis. |
| Q58715507 | Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study |
| Q101038971 | Stroke prevention strategies in high-risk patients with atrial fibrillation |
| Q55400701 | Updates on Prevention of Hemorrhagic and Lacunar Strokes. |
Search more.